D. Leger, Public health and insomnia: economic impact, Sleep, vol.23, issue.3, pp.69-76, 2000.

J. Walsh, Clinical and socioeconomic correlates of insomnia, J Clin Psychiatry, vol.65, issue.8, pp.13-22, 2004.

D. Buysse, Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD- 10 categories: a report from the APA/NIMH DSM-IV Field Trial, Sleep, issue.7, pp.17630-17637, 1994.

D. Leger, E. Levy, and M. Paillard, The direct costs of insomnia in France, Sleep, vol.22, issue.2, pp.394-401, 1999.

J. Glass, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits, BMJ, vol.331, issue.7526, p.3311169, 2005.
DOI : 10.1136/bmj.38623.768588.47

R. Leipzig, R. Cumming, and M. Tinetti, Drugs and Falls in Older People: A Systematic Review and Meta-analysis: II. Cardiac and Analgesic Drugs, Journal of the American Geriatrics Society, vol.331, issue.Suppl 4, pp.40-50, 1999.
DOI : 10.1111/j.1532-5415.1999.tb01899.x

J. Verster, Hypnotics and Driving Safety: Meta-Analyses of Randomized Controlled Trials Applying the on-the-Road Driving Test, Current Drug Safety, vol.1, issue.1, pp.63-71, 2006.
DOI : 10.2174/157488606775252674

B. Claustrat, J. Brun, and G. Chazot, The basic physiology and pathophysiology of melatonin, Sleep Medicine Reviews, vol.9, issue.1, pp.11-24, 2005.
DOI : 10.1016/j.smrv.2004.08.001

V. Butterweck, Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice, Journal of Pharmacy and Pharmacology, vol.102, issue.4, pp.549-52, 2007.
DOI : 10.1211/jpp.59.4.0009

C. Miranda, Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3- methylimidazo[4, 5-f ]quinoline, mediated by cDNA-expressed human CYP1A2, Drug Metab Dispos, issue.11, pp.281297-302, 2000.

A. Wade, Efficacy of prolonged release melatonin in insomnia patients aged 55???80 years: quality of sleep and next-day alertness outcomes, Current Medical Research and Opinion, vol.23, issue.10, pp.2597-605, 2007.
DOI : 10.1185/030079907X233098

P. Lemoine, Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55??years and older and has no withdrawal effects, Journal of Sleep Research, vol.12, issue.4, pp.372-80, 2007.
DOI : 10.1002/ddr.20014

J. Baskett, Does melatonin improve sleep in older people? A randomised crossover trial, Age and Ageing, vol.32, issue.2, pp.164-70, 2003.
DOI : 10.1093/ageing/32.2.164

A. Academy and S. Medicine, The international classification of sleep disorders, Diagnostic and coding manual, pp.6-8, 2005.

C. Bastien, A. Vallieres, and C. Morin, Validation of the Insomnia Severity Index as an outcome measure for insomnia research, Sleep Medicine, vol.2, issue.4, pp.297-307, 2001.
DOI : 10.1016/S1389-9457(00)00065-4

D. Sheehan, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, vol.59, pp.22-33, 1998.

A. Beck, W. Rial, and K. Rickels, Short form of depression inventory: crossvalidation, Psychol Rep, vol.34, issue.3, pp.1184-1190, 1974.

M. Johns, A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, issue.6, pp.540-545, 1991.
DOI : 10.1093/sleep/14.6.540

R. Tarrasch, M. Laudon, and N. Zisapel, Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients, Human Psychopharmacology: Clinical and Experimental, vol.18, issue.8, pp.603-613, 2003.
DOI : 10.1002/hup.534

N. Zisapel and M. Laudon, Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review, Human Psychopharmacology: Clinical and Experimental, vol.34, issue.1, pp.1-20, 2003.
DOI : 10.1002/hup.455

J. Horne and O. Ostberg, A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms, Int J Chronobiol, vol.4, issue.2, pp.97-110, 1976.

B. Claustrat, A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression, Biol Psychiatry, vol.19, issue.8, pp.1215-1243, 1984.

C. Harthe, Direct radioimmunoassay of 6-sulfatoxymelatonin in plasma with use of an iodinated tracer, Clin Chem, vol.37, issue.4, pp.536-545, 1991.

I. Hindmarch, A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality, Psychopharmacology, vol.149, issue.3, pp.203-219, 2000.
DOI : 10.1007/s002130000383

W. Mccall, D. Agostino, R. Jr, and A. Dunn, A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials, Sleep Medicine, vol.4, issue.1, pp.57-62, 2003.
DOI : 10.1016/s1389-9457(02)00242-3

S. Bent, Valerian for Sleep: A Systematic Review and Meta-Analysis, The American Journal of Medicine, vol.119, issue.12
DOI : 10.1016/j.amjmed.2006.02.026

C. Morin, Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial, Sleep, vol.28, issue.11, pp.1465-71, 2005.

W. Dimpfel and A. Suter, Sleep improving effects of a single dose administration of a valerian/hops fluid extract. A double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using the electrohypnogram, Zeitschrift f??r Phytotherapie, vol.29, issue.S 1, pp.200-204, 2008.
DOI : 10.1055/s-2008-1047853

Q. Regestein and T. Monk, Delayed sleep phase syndrome: a review of its clinical aspects, Am J Psychiatry, vol.152, issue.4, pp.602-610, 1995.